Systematic Lateral Prostate Biopsy-Are the Benefits Worth the Costs?

Journal of Urology

Volumn 179, Issue 4, 2008, Pages 1321-1326

  Neill, Mischel G ^b   Toi, Ants ^a   Lockwood, Gina A ^b   Evans, Andrew ^a   Tammsalu, Lisa ^a   Fleshner, Neil E ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

adenocarcinoma; biopsy; cost benefit analysis; prostate; ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COST BENEFIT ANALYSIS; GLEASON SCORE; HEALTH CARE COST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; QUANTITATIVE ANALYSIS; TIME SERIES ANALYSIS; TRANSRECTAL ULTRASONOGRAPHY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COST-BENEFIT ANALYSIS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC DISEASES; PROSTATIC NEOPLASMS;

EID: 40849102305     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.11.065     Document Type: Article

References (20)

1. Hodge K.K., McNeal J.E., Terris M.K., and Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71
2. Terris M.K., Pham T.Q., Issa M.M., and Kabalin J.N. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 157 (1997) 204
3. Presti J.C., Chang J.J., Bhargava V., and Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163 (2000) 163
4. Eskew L.A., Bare R.L., and McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157 (1997) 199
5. Levine M.A., Ittman M., Melamed J., and Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159 (1998) 471
6. Toi A., Neill M.G., Lockwood G.A., Sweet J.M., Tammsalu L.A., and Fleshner N.E. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 177 (2007) 516
7. Gore J.L., Shariat S.F., Miles B.J., Kadmon D., Jiang N., Wheeler T.M., et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165 (2001) 1554
8. Chang J.J., Shinohara K., Bhargava V., and Presti J.C. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160 (1998) 2111
9. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumour extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368
10. Bastian P.J., Mangold L.A., Epstein J.I., and Partin A.W. Characteristics of insignificant clinical T1c prostate tumours: a contemporary analysis. Cancer 101 (2004) 2001
11. Ng L.G., Tan P.H., Yuen J., Lau W., and Cheng C. Improved detection rate of prostate cancer using the 10-core biopsy strategy in Singapore. Asian J Surg 25 (2002) 238
12. Brossner C., Madersbacher S., Bayer G., Pycha A., Klingler H.C., and Maier U. Comparative study of two different TRUS-guided sextant biopsy techniques in detecting prostate cancer in one biopsy session. Eur Urol 31 (2000) 65
13. Naughton C.K., Miller D.C., Mager D.E., Ornstein D.K., and Catalona W.J. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164 (2000) 388
14. Norberg M., Egevad L., Holmberg L., Sparen P., Norlen B.J., and Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50 (1997) 562
15. Terris M.K., Wallen E.M., and Stamey T.A. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int 59 (1997) 239
16. Durkan G.C., Sheikh N., Johnson P., Hildreth A.J., and Greene D.R. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int 89 (2002) 33
17. Eskicorapci S.Y., Guliyev F., Akdogan B., Dogan H.S., Ergen A., and Ozen H. Individualization of the biopsy protoco0l according to the prostate gland volume for prostate cancer detection. J Urol 173 (2005) 1536
18. Al-Ghazo M.A., Ghalayini I.F., and Matalka I.I. Ultrasound-guided transrectal extended prostate biopsy: a prospective study. Asian J Androl 7 (2005) 165
19. Winkler M.H., Kulinskaya E., and Gillatt D.A. Prediction of prostate cancer in extended-field biopsies of the prostate. BJU Int 93 (2004) 516
20. Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parnes H.L., et al. Prevalence of prostate cancer among men with a prostate specific antigen level ≤4.0 ng per milliliter. N Engl J Med 350 (2004) 2239